Visible-light-mediated modification and manipulation of biomacromolecules

VM Lechner, M Nappi, PJ Deneny, S Folliet… - Chemical …, 2021 - ACS Publications
Chemically modified biomacromolecules─ ie, proteins, nucleic acids, glycans, and lipids─
have become crucial tools in chemical biology. They are extensively used not only to …

Nanocatalytic medicine

B Yang, Y Chen, J Shi - Advanced materials, 2019 - Wiley Online Library
Catalysis and medicine are often considered as two independent research fields with their
own respective scientific phenomena. Promoted by recent advances in nanochemistry, large …

Photonic carbon dots as an emerging nanoagent for biomedical and healthcare applications

YJ Chung, J Kim, CB Park - ACS nano, 2020 - ACS Publications
As a class of carbon-based nanomaterials, carbon dots (CDs) have attracted enormous
attention because of their tunable optical and physicochemical properties, such as …

Interrogating biological systems using visible-light-powered catalysis

KA Ryu, CM Kaszuba, NB Bissonnette… - Nature Reviews …, 2021 - nature.com
Light-powered catalysis has found broad utility as a chemical transformation strategy, with
widespread impact on energy, environment, drug discovery and human health. A noteworthy …

Photomodulating carbon dots for spatiotemporal suppression of Alzheimer's β-amyloid aggregation

YJ Chung, CH Lee, J Lim, J Jang, H Kang, CB Park - ACS nano, 2020 - ACS Publications
Extracellular deposition of β-amyloid (Aβ) peptide aggregates is a major characteristic of
Alzheimer's disease (AD) brain. Because Aβ peptide aggregates aggravate neuropathy and …

Porphyrinic metal–organic framework PCN-224 nanoparticles for near-infrared-induced attenuation of aggregation and neurotoxicity of Alzheimer's amyloid-β peptide

J Wang, Y Fan, Y Tan, X Zhao, Y Zhang… - … applied materials & …, 2018 - ACS Publications
The aberrant aggregation of amyloid-β peptide (Aβ) in the brain has been considered as the
major pathological hallmark of Alzheimer's diseases (AD). Inhibition of Aβ aggregation is …

Catalytic photooxygenation degrades brain Aβ in vivo

N Nagashima, S Ozawa, M Furuta, M Oi, Y Hori… - Science …, 2021 - science.org
Protein degradation induced by small molecules by recruiting endogenous protein
degradation systems, such as ubiquitin-proteasome systems, to disease-related proteins is …

Near‐Infrared Switchable Fullerene‐Based Synergy Therapy for Alzheimer's Disease

Z Du, N Gao, X Wang, J Ren, X Qu - Small, 2018 - Wiley Online Library
C60 has a special dual function; it can act as both a powerful reactive oxygen species (ROS)
producer under UV or visible light and an ROS scavenger in the dark. However, ROS has …

Photodynamic Alzheimer's disease therapy: From molecular catalysis to photo-nanomedicine

Y Xu, H Xiong, B Zhang, I Lee, J Xie, M Li… - Coordination Chemistry …, 2022 - Elsevier
Alzheimer's disease (AD) is a major form of dementia, closely associated with the
filamentous assembly of amyloid-β (Aβ) and Tau protein in the brain, which can cause …

Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: a review

W Liu, X Dong, Y Liu, Y Sun - Acta Biomaterialia, 2021 - Elsevier
The abnormal self-assembly of amyloid-β protein (Aβ) into toxic aggregates is a major
pathological hallmark of Alzheimer's disease (AD). Modulation of Aβ fibrillization with …